The efficacy of the PD-L1 blockade in reinvigorating tumor-infiltrating TRM cells depends on Bhlhe40, and Bhlhe40 might therefore constitute a nexus between immunomodulatory signals, metabolism, and functionality of tissue-resident T cell populations. Here, BHLHE40 is linked to neoplasm.